Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survivors of childhood brain cancer are more likely to be held back in school

2.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

3.

Patients value communication skills from cancer surgeons across six key areas, according to research

4.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

5.

Young adults who are obese are at risk for 17 different types of cancer in the future.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot